Innovent Biologics, Inc. (1801.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
| Market Cap | 118.55B |
| Enterprise Value | 104.02B |
| P/E Ratio | 131.77 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 8.73 |
| Price/Book Ratio | 5.8 |
| Enterprise/Revenue | 7.61 |
| Enterprise/EBITDA | 75.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.06 |
| Operating Margin | 0.06 |
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
| Revenue | 13.04B |
| Revenue/Share | 7.62 |
| Gross Profit | 10B |
| EBITDA | 1.31B |
| Net Income | 813.57M |
| Diluted EPS | 0.47 |
| Total Cash | 18.24B |
| Total Cash/Share | 10.65 |
| Total Debt | 2.82B |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2.62 |
| Book Value Per Share | 11.78 |
| 52-Week Change | -3.8 |
| 52-Week High | 109.1 |
| 52-Week Low | 69.55 |
| Moving Average 50 Days | 83.05 |
| Moving Average 200 Days | 86.38 |
| Average Volume | 13.16M |
| Shares Outstanding | 1.73B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |